Literature DB >> 7672058

Prevalence of antibodies to Yersinia enterocolitica O:3 among Norwegian military recruits: association with risk factors and clinical manifestations.

A Saebø1, G Kapperud, J Lassen, J Waage.   

Abstract

IgG antibody activity to Yersinia enterocolitica serogroup O:3 was detected in sera from 56 (7.4%) of 755 Norwegian military recruits, using an enzyme-linked immunosorbent assay. The highest prevalence was found among recruits from Oslo city (12/56, 21.4%). The recruits answered a questionnaire which covered demographic data, specific exposures, and clinical information. The following risk factors were found to be independently associated with IgG activity in logistic regression analysis: receiving drinking water from a private well (odds ratio (OR) = 3.40; p = 0.004), being a resident of Oslo city (OR = 2.99; p = 0.006), and living in eastern Norway (OR = 2.25; p = 0.015). By univariate analysis, living in an urban area was associated with IgG activity, but this factor did not independently affect risk. Present or previous contact with animals, including pigs, and travels abroad were not associated with an increased risk. Yersinia enterocolitica O:3 seropositive recruits were more likely to report previous surgery for suspected appendicitis than seronegative individuals (OR = 4.26; p = 0.0024). Among recruits with previous appendectomy, mesenteric lymphadenitis as the sole peroperative finding was more common in patients with IgG activity to Y. enterocolitica O:3 (4/7) than in seronegative patients (1/19) (p = 0.01). Recurrent diarrhea, steatorrhea or joint complaints were not associated with antibody activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7672058     DOI: 10.1007/bf01719293

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  33 in total

1.  HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease.

Authors:  K Aho; P Ahvonen; A Lassus; K Sievers; A Tiilikainen
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

2.  Yersiniosis as an internal disease.

Authors:  R Leino; J L Kalliomäki
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

Review 3.  Studies on Yersinia enterocolitica with special reference to bacterial diagnosis and occurrence in human acute enteric disease.

Authors:  B Niléhn
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1969

4.  Yersinia enterocolitica (Pasteurella x) in human enteric infections.

Authors:  S Winblad; B Niléhn; N H Sternby
Journal:  Br Med J       Date:  1966-12-03

5.  Yersinia enterocolitica infection in patients with acute surgical abdominal disease. A prospective study.

Authors:  O B Jepsen; B Korner; K B Lauritsen; A B Hancke; L Andersen; S Henrichsen; E Brenoe; P M Christiansen; A Johansen
Journal:  Scand J Infect Dis       Date:  1976

Review 6.  A survey of acute and chronic disease associated with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients.

Authors:  A Saebø; J Lassen
Journal:  Scand J Infect Dis       Date:  1991

7.  Yersinia enterocolitica infections and rheumatic diseases.

Authors:  J H Larsen
Journal:  Scand J Rheumatol       Date:  1980       Impact factor: 3.641

8.  Glomerulonephritis in infections with Yersinia enterocolitica O-serotype 3. II. The incidence and immunological features of Yersinia infection in a consecutive glomerulonephritis population.

Authors:  M Friedberg; T Denneberg; C Brun; J H Larsen; S Larsen
Journal:  Acta Med Scand       Date:  1981

9.  Sources of sporadic Yersinia enterocolitica infections in Norway: a prospective case-control study.

Authors:  S M Ostroff; G Kapperud; L C Hutwagner; T Nesbakken; N H Bean; J Lassen; R V Tauxe
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

10.  Yersinia enterocolitica and Yersinia like microbes isolated from mammals and water in Norway and Denmark.

Authors:  G Kapperud
Journal:  Acta Pathol Microbiol Scand B       Date:  1977-04
View more
  1 in total

1.  Current evidence for human yersiniosis in Ireland.

Authors:  T Ringwood; B P Murphy; N Drummond; J F Buckley; A P Coveney; H P Redmond; J P Power; S Fanning; M B Prentice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-03       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.